Spots Global Cancer Trial Database for Laparoscopic Assisted Transanal Resection of Rectal Cancer With Total Mesorectal Excision

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Laparoscopic Assisted Transanal Resection of Rectal Cancer With Total Mesorectal Excision

Official Title: Laparoscopic Assisted Transanal Resection of Rectal Cancer With Total Mesorectal Excision

Study ID: NCT03171298

Conditions

Rectal Cancer

Interventions

Laparoscopic Assisted Transanal Total Mesorectal Excision

Study Description

Brief Summary: Rectal cancer is one of the frequent malignant neoplasms ,Total mesorectal excision (TME) has become the gold standard treatment for middle and lower rectal cancers. Laparoscopic TME still be difficult in patients with low rectal tumors, narrow pelvic anatomy, male sex or high body mass index . Difficult visualization of the pelvic anatomy along with the limitation of rigid laparoscopic instruments may affect the quality of oncological outcomes and increase the risks of injuries during surgery. A down to up approach via transanal total mesorectal excision (TaTME) technique may overcome these problems

Detailed Description: This clinical trial will be conducted at general surgery department of Assiut University Hospital . .